Brain-derived neurotrophic factor-enriched collagen tubule as a substitute for autologous nerve grafts

D. J. Terris, K. M. Toft, M. Moir, J. Lum, M. Wang

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Background: Autologous nerve interposition grafts are frequently harvested by head and neck surgeons. The sacrifice of these donor nerves guarantees some degree of morbidity, including sensory loss, additional incision sites with associated potential complications, and prolonged operative time. An alternative to autologous nerve grafting is, therefore, desirable. Objective: To determine if a collagen tubule (CT) filled with either a plain collagen gel or a brain-derived neurotrophic factor (BDNF)-enriched collagen gel could be used to achieve functional and histologic outcomes equivalent to an autologous nerve graft in bridging a 15-mm nerve gap in the rabbit facial nerve. Design: A prospective, randomized, blinded animal study with a control group. Methods: Thirty rabbit facial nerves were resected (15-mm segments) to create nerve gaps. The gaps were bridged using 1 of 3 methods, assigned randomly: a reversed facial nerve (control), a collagen gel-filled CT, or a BDNF-enriched collagen gel-filled CT. The animals were evaluated after 6 weeks in a blinded fashion for functional nerve recovery, axon count, and axonal diameter. Results: There were no significant differences between the autologous nerve graft group, the collagen gel-filled CT group, or the BDNF-enriched collagen gel-filled CT group (n = 10 for each group) for functional nerve recovery (P = .94). The mean axon count and the mean axonal diameter were highest in the BDNF-enriched collagen gel-filled CT group, but these differences failed to reach statistical significance (P = .18 and .96, respectively). Conclusions: Collagen tubules filled with BDNF-enriched collagen gel appear to be at least as good as autologous nerve grafts for bridging short facial nerve gaps. Larger experimental studies are warranted to determine if clinical trials are justified.

Original languageEnglish (US)
Pages (from-to)294-298
Number of pages5
JournalArchives of Otolaryngology - Head and Neck Surgery
Volume127
Issue number3
DOIs
StatePublished - Jan 1 2001

Fingerprint

Brain-Derived Neurotrophic Factor
Collagen
Transplants
Gels
Facial Nerve
Axons
Rabbits
Operative Time

ASJC Scopus subject areas

  • Surgery
  • Otorhinolaryngology

Cite this

Brain-derived neurotrophic factor-enriched collagen tubule as a substitute for autologous nerve grafts. / Terris, D. J.; Toft, K. M.; Moir, M.; Lum, J.; Wang, M.

In: Archives of Otolaryngology - Head and Neck Surgery, Vol. 127, No. 3, 01.01.2001, p. 294-298.

Research output: Contribution to journalArticle

@article{a13838ad3b1a4496983638ba41700536,
title = "Brain-derived neurotrophic factor-enriched collagen tubule as a substitute for autologous nerve grafts",
abstract = "Background: Autologous nerve interposition grafts are frequently harvested by head and neck surgeons. The sacrifice of these donor nerves guarantees some degree of morbidity, including sensory loss, additional incision sites with associated potential complications, and prolonged operative time. An alternative to autologous nerve grafting is, therefore, desirable. Objective: To determine if a collagen tubule (CT) filled with either a plain collagen gel or a brain-derived neurotrophic factor (BDNF)-enriched collagen gel could be used to achieve functional and histologic outcomes equivalent to an autologous nerve graft in bridging a 15-mm nerve gap in the rabbit facial nerve. Design: A prospective, randomized, blinded animal study with a control group. Methods: Thirty rabbit facial nerves were resected (15-mm segments) to create nerve gaps. The gaps were bridged using 1 of 3 methods, assigned randomly: a reversed facial nerve (control), a collagen gel-filled CT, or a BDNF-enriched collagen gel-filled CT. The animals were evaluated after 6 weeks in a blinded fashion for functional nerve recovery, axon count, and axonal diameter. Results: There were no significant differences between the autologous nerve graft group, the collagen gel-filled CT group, or the BDNF-enriched collagen gel-filled CT group (n = 10 for each group) for functional nerve recovery (P = .94). The mean axon count and the mean axonal diameter were highest in the BDNF-enriched collagen gel-filled CT group, but these differences failed to reach statistical significance (P = .18 and .96, respectively). Conclusions: Collagen tubules filled with BDNF-enriched collagen gel appear to be at least as good as autologous nerve grafts for bridging short facial nerve gaps. Larger experimental studies are warranted to determine if clinical trials are justified.",
author = "Terris, {D. J.} and Toft, {K. M.} and M. Moir and J. Lum and M. Wang",
year = "2001",
month = "1",
day = "1",
doi = "10.1001/archotol.127.3.294",
language = "English (US)",
volume = "127",
pages = "294--298",
journal = "JAMA Otolaryngology - Head and Neck Surgery",
issn = "2168-6181",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - Brain-derived neurotrophic factor-enriched collagen tubule as a substitute for autologous nerve grafts

AU - Terris, D. J.

AU - Toft, K. M.

AU - Moir, M.

AU - Lum, J.

AU - Wang, M.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Background: Autologous nerve interposition grafts are frequently harvested by head and neck surgeons. The sacrifice of these donor nerves guarantees some degree of morbidity, including sensory loss, additional incision sites with associated potential complications, and prolonged operative time. An alternative to autologous nerve grafting is, therefore, desirable. Objective: To determine if a collagen tubule (CT) filled with either a plain collagen gel or a brain-derived neurotrophic factor (BDNF)-enriched collagen gel could be used to achieve functional and histologic outcomes equivalent to an autologous nerve graft in bridging a 15-mm nerve gap in the rabbit facial nerve. Design: A prospective, randomized, blinded animal study with a control group. Methods: Thirty rabbit facial nerves were resected (15-mm segments) to create nerve gaps. The gaps were bridged using 1 of 3 methods, assigned randomly: a reversed facial nerve (control), a collagen gel-filled CT, or a BDNF-enriched collagen gel-filled CT. The animals were evaluated after 6 weeks in a blinded fashion for functional nerve recovery, axon count, and axonal diameter. Results: There were no significant differences between the autologous nerve graft group, the collagen gel-filled CT group, or the BDNF-enriched collagen gel-filled CT group (n = 10 for each group) for functional nerve recovery (P = .94). The mean axon count and the mean axonal diameter were highest in the BDNF-enriched collagen gel-filled CT group, but these differences failed to reach statistical significance (P = .18 and .96, respectively). Conclusions: Collagen tubules filled with BDNF-enriched collagen gel appear to be at least as good as autologous nerve grafts for bridging short facial nerve gaps. Larger experimental studies are warranted to determine if clinical trials are justified.

AB - Background: Autologous nerve interposition grafts are frequently harvested by head and neck surgeons. The sacrifice of these donor nerves guarantees some degree of morbidity, including sensory loss, additional incision sites with associated potential complications, and prolonged operative time. An alternative to autologous nerve grafting is, therefore, desirable. Objective: To determine if a collagen tubule (CT) filled with either a plain collagen gel or a brain-derived neurotrophic factor (BDNF)-enriched collagen gel could be used to achieve functional and histologic outcomes equivalent to an autologous nerve graft in bridging a 15-mm nerve gap in the rabbit facial nerve. Design: A prospective, randomized, blinded animal study with a control group. Methods: Thirty rabbit facial nerves were resected (15-mm segments) to create nerve gaps. The gaps were bridged using 1 of 3 methods, assigned randomly: a reversed facial nerve (control), a collagen gel-filled CT, or a BDNF-enriched collagen gel-filled CT. The animals were evaluated after 6 weeks in a blinded fashion for functional nerve recovery, axon count, and axonal diameter. Results: There were no significant differences between the autologous nerve graft group, the collagen gel-filled CT group, or the BDNF-enriched collagen gel-filled CT group (n = 10 for each group) for functional nerve recovery (P = .94). The mean axon count and the mean axonal diameter were highest in the BDNF-enriched collagen gel-filled CT group, but these differences failed to reach statistical significance (P = .18 and .96, respectively). Conclusions: Collagen tubules filled with BDNF-enriched collagen gel appear to be at least as good as autologous nerve grafts for bridging short facial nerve gaps. Larger experimental studies are warranted to determine if clinical trials are justified.

UR - http://www.scopus.com/inward/record.url?scp=0035092198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035092198&partnerID=8YFLogxK

U2 - 10.1001/archotol.127.3.294

DO - 10.1001/archotol.127.3.294

M3 - Article

C2 - 11255474

AN - SCOPUS:0035092198

VL - 127

SP - 294

EP - 298

JO - JAMA Otolaryngology - Head and Neck Surgery

JF - JAMA Otolaryngology - Head and Neck Surgery

SN - 2168-6181

IS - 3

ER -